InvestorsHub Logo
Followers 8
Posts 508
Boards Moderated 0
Alias Born 07/04/2014

Re: None

Thursday, 10/23/2014 6:36:30 AM

Thursday, October 23, 2014 6:36:30 AM

Post# of 80490
Ponatinib in the leukemia world: why a reevaluation is necessary for Philadelphia chromosome-positive patients with T315I mutation.

Link


Already known?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.